EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Hepatic arterial infusion chemotherapy–based triplet conversion therapy for hepatocellular carcinoma with portal vein tumor thrombus: Evidence, patient selection, and surgical endpoints

Chaosheng Xia, Yutao He, Rongfu Hong, Wenda Wang, Hangyu Li, Lin Wang, Zhitian Shi

BioScience Trends · 2026

DOI: 10.5582/bst.2026.01217 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift BioScience Trends, 2026. Verfasst von Chaosheng Xia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, China. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Hepatocellular, Liver Neoplasms, Venous Thrombosis. Die Arbeit nennt 63 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Combined Chemotherapy ProtocolsCarcinoma, HepatocellularLiver NeoplasmsVenous ThrombosisHumansAngiogenesis InhibitorsCombined Modality TherapyHepatectomyHepatic ArteryImmune Checkpoint InhibitorsInfusions, Intra-ArterialPatient SelectionPortal Vein

Stichwörter der Autor:innen

antiangiogenesisdownstaginghepatectomyimmune checkpoint inhibitionportal hypertension

Substanzen

Angiogenesis InhibitorsImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Second Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.

Zitieren

APA

Xia, C., He, Y., Hong, R., Wang, W., Li, H., Wang, L., & Shi, Z. (2026). Hepatic arterial infusion chemotherapy–based triplet conversion therapy for hepatocellular carcinoma with portal vein tumor thrombus: Evidence, patient selection, and surgical endpoints. BioScience Trends. https://doi.org/10.5582/bst.2026.01217

Vancouver

Xia C, He Y, Hong R, Wang W, Li H, Wang L, et al. Hepatic arterial infusion chemotherapy–based triplet conversion therapy for hepatocellular carcinoma with portal vein tumor thrombus: Evidence, patient selection, and surgical endpoints. BioScience Trends. 2026. doi:10.5582/bst.2026.01217

BibTeX
@article{Xia2026,
  author = {Xia, Chaosheng and He, Yutao and Hong, Rongfu and Wang, Wenda and Li, Hangyu and Wang, Lin and Shi, Zhitian},
  title = {Hepatic arterial infusion chemotherapy–based triplet conversion therapy for hepatocellular carcinoma with portal vein tumor thrombus: Evidence, patient selection, and surgical endpoints},
  journal = {BioScience Trends},
  year = {2026},
  doi = {10.5582/bst.2026.01217}
}
Kostenlos starten →